Phibro Animal Health (PAHC) Revenue (2012 - 2026)

Phibro Animal Health's Revenue history runs 15 years deep, the most recent figure standing at $383.5 million for Q1 2026.

• In Q1 2026, Revenue rose 10.27% year-over-year to $383.5 million; the TTM figure through Mar 2026 stood at $1.5 billion (up 25.98% YoY), while the FY2025 annual figure was $1.3 billion, up 27.37% from the prior year.
• Revenue was $383.5 million for Q1 2026 at Phibro Animal Health, up from $373.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $383.5 million in Q1 2026 to a low of $231.3 million in Q3 2023.
• Historically, Revenue has averaged $288.7 million across 5 years, with a median of $260.4 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Revenue declined 0.5% in 2023, then surged 39.73% in 2025.
• A 5-year view of Revenue shows it stood at $244.6 million in 2022, then rose by 2.17% to $249.9 million in 2023, then advanced by 23.73% to $309.3 million in 2024, then advanced by 20.9% to $373.9 million in 2025, then rose by 2.58% to $383.5 million in 2026.
• The last three Revenue figures came in at $383.5 million (Q1 2026), $373.9 million (Q4 2025), and $363.9 million (Q3 2025), per Business Quant data.